Sales of Eli Lilly and Co.’s newest drug were an afterthought during its Oct. 21 report on third-quarter earnings. The blood thinner Effient totaled up $22.6 million in sales—a mere 0.4 percent of Lilly’s total for
the quarter.
You know, there’s an election on Nov. 3, right? We’re not voting for president, governor,
mayor, or even dog catcher. We’re voting for a critical piece of the health care delivery system in central Indiana: whether to allow Marion County
Health & Hospital Corp. to sell bonds to build a new Wishard Hospital.
CEO John Lechleiter says Lilly’s pipeline has helped it rebound from significant patent losses three times during his 30-year
career at the company. He’s betting there will be a fourth.
Goodwill Industries executive Keith Reissaus has been tapped to run Washington, D.C.-based Leapfrog Group, an industry coalition.
Reissaus gained control of health care costs by giving employees incentives to care about their health.
Eli Lilly and Co. and General Electric Co. say they’ve made a breakthrough in cancer research that could help Lilly cut the size and cost of its clinical trials.
Excluding special items, Eli Lilly and Co.’s earnings per share spike 22 percent on the strength of Alimta, Cymbalta and Humalog
sales. Lilly’s revenue rose 7 percent in the quarter over the same period of 2008,
to $5.56 billion.
Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world’s second-best selling drug, with
Effient, a potential blockbuster drug sold by Indianapolis-based Eli Lilly and Co.
Founder of medical device firm says Congress should fund network of low-cost clinics.
Fear of death may be causing Americans to expect too much from our medical system when it comes to prolonging the lives of
the old and infirm.
West Lafayette-based Endocyte Inc. announced Friday that it has closed on $26 million in equity financing to help the company
continue developing cancer-fighting drugs.
Some of Indiana’s leading organizations in health information technology are collaborating on an effort to receive several
million dollars of stimulus funding.
As health care legislation
continues to wend its way through Congress, Indianapolis-area industry leaders still harbor strong
opinions about the issue. Five industry insiders discussed how to improve the health care system during
IBJ’s Power Breakfast Sept. 25 at the Westin Indianapolis.
Doctors are considering their options as health care reform gains momentum.
A peer-review panel of experts would help minimize unnecessary medical malpractice suits.
Nearly 700 workers will be offered severance, new jobs
UnitedHealthcare has become the second health insurer to join Quality Health First, a pay-for-performance program operated
by the Indiana Health Information Exchange, the exchange announced Tuesday.
The insurance industry sharply escalated its criticism of the Senate health care bill Sunday, charging that the legislation
would shift costs to privately insured people, raising the price of a typical policy by hundreds, if not thousands, of dollars
annually.
Shares of WellPoint Inc. partially recovered Friday morning after a plunge was touched off Thursday by gathering momentum behind health care reform and talk of a windfall-profit tax by Speaker of the House Nancy Pelosi.
The health reform bill sponsored by U.S. Sen. Max Baucus, D-Mont., would help pay for expanded health insurance coverage
by levying fees of $13 billion a year on the health care industry. The fees would deliver a hefty bill to just
about all of Indiana’s major health care companies. But how they’re reacting to the fees is all over the map.
The business park would encompass about 900 acres on the town’s northeast side and require rezoning
of much of the land, from residential and agriculture to commercial.
